In biotechnology, many promising projects fail to reach the investment stage due to incomplete preparation—missing key team members, lack of efficacy data, or insufficient intellectual property protection. NIVIRON can take full responsibility for upgrading such projects so they meet investor requirements and are ready for the next stage of growth.

We provide:

• Team completion — engaging key technical, scientific, and management talent.
• Attraction of alternative funding sources — grants, joint research with strategic partners, sponsorship of preclinical stages.
• Advancing the technology stage and available data — organizing preclinical studies to confirm efficacy and safety.
• Intellectual property protection — developing and executing a patent strategy.
• Preparation of the company’s legal and organizational structure — aligned with investor and regulatory standards.
• Jurisdiction change — when needed, to improve investment appeal.
• Business model adjustment — adapting to market needs, scaling strategies, and investor requirements.

Result: the project re-enters the investor’s pipeline at a higher investment readiness stage, with stronger chances of advancing to the next stage of technology development and securing subsequent funding rounds.